Highlight of 2018
This year’s event had plenty of debates and discussions as well as a good mix of traditional presentations which gave the audience a chance to interact with our speakers. It gave our audience a chance to take away ideas to have with our speakers. We have included the foremost and innovative companies as well as the large pharmaceuticals who were on hand to provide expertise and scope. There were many star speakers that stood out for the 2 days including:
- Stand out speaker, Dirk Weber, the current CMO from Cellestia Biotech AG/Aurealis Pharma AG was interviewed to speak more about his experience on how he has successfully partnered up with external solution providers and what he felt were the best methods to build a new relationship and the angles he feels are best for small pharmaceuticals. He also took over for the chairman for day 2 of this conference.
- Marie Laurencin, Senior Trial Lead, Novartis and Ruth Proebe, Associate Director, CR Bard were engaging and discussed effortlessly their interactive panel discussions which also answered questions from audience members and discussed their opinions between Full-Service and Functional outsourcing. With the stand point from either side, this was definitely a stand out discussion which encouraged a conversation from the audience members.
- Francois Curtin, COO of Geneuro discussed traditionally a presentation focused towards the end trials and pinpointing the key milestones within a project to focus on hand what are the best financial anchors needed for a smoother run and operationally define end points.
We look forward to seeing you in 2019.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948